Aug 22 |
Moderna, Pfizer updated mRNA COVID vaccines authorized by FDA
|
Aug 22 |
Pfizer and BioNTech Receive U.S. FDA Approval & Authorization for Omicron KP.2-adapted COVID-19 Vaccine
|
Aug 22 |
The FDA Approved a New Covid Vaccine. Should You Get It?
|
Aug 21 |
Pfizer forecasts $26bn of Covid-19 vaccine revenue after first-quarter success
|
Aug 20 |
BioNTech: Clinical Hold Removal Pushes ADC Development Program Forward
|
Aug 20 |
FDA greenlights BioNTech/Medilink’s cancer trial at lower dose after deaths
|
Aug 19 |
Partial hold on BioNTech, MediLink cancer drug lifted by FDA
|
Aug 19 |
FDA Allows Resumption Of BioNTech/MediLink Therapeutics Partnered Phase 1 Study For Cancer Drug With Lower Dose
|
Aug 19 |
FDA Allows Resumption Of BioNTech/MediLink Therapeutics Partnered Phase 1 Study For Cancer Drug With Lower Dose
|
Aug 19 |
Pfizer (PFE), BioNTech COVID-Flu Combo Shot Study Falters
|